Sodium O-Acetyl-(R)-Isoxazol-3-Yl((2-Oxo-3-(2,3,5-Trifluoro-4-(4-Oxo-3,4-Dihydropyridin-1(2H)-Yl)Phenyl)Oxazolidin-5-Yl)Methyl)Phosphoramidate — Drug Intelligence | 1 EU Trials

Filter these 1 trials by condition, phase, country and more.

1 Registered trials

1 Recruiting

0 Completed trials

1 Sponsors

15 Countries

Phase III

Phase III: 1

Indications tested

1 total

Showing 1–1 of 1 trials